Stephen A. Trowbridge - 22 Jul 2026 Form 4 Insider Report for ANGIODYNAMICS INC (ANGO)

Reporting relationship: EVP and CFO
Issuer ticker: ANGO
Reported as of: 22 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jul 2026, 18:10:53 UTC
Prior SEC filing: 21 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Lawrence T. Weiss, as Attorney in Fact

Key filing fact

Stephen A. Trowbridge filed Form 4 for ANGIODYNAMICS INC (ANGO) on 24 Jul 2026.

Key facts

This page summarizes Stephen A. Trowbridge's Form 4 filing for ANGIODYNAMICS INC (ANGO).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 Jul 2026, 18:10.

Change

Previous filing in this sequence was filed on 21 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001624250 Primary reporting owner

Trowbridge Stephen A

Relationship: EVP and CFO
Address: 14 PLAZA DRIVE, LATHAM
Signature: /s/ Lawrence T. Weiss, as Attorney in Fact
Signature date: 24 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ANGO transaction

Common Stock

Options Exercise

Transaction value
Shares: +16,296
Change %: +5.5%
Price: $0.000000^*
Shares after: 314,115
Date: 22 Jul 2026
Ownership: Direct
Footnotes: F1

ANGO transaction

Common Stock

Tax liability

Transaction value
Shares: -8,319
Change %: -2.6%
Price: $13.82^*
Shares after: 305,796
Date: 22 Jul 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ANGO transaction Derivative

Performance Right

Options Exercise

Transaction value
Shares: -57,381
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 22 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 57,381
Exercise price
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This acquisition of 16,296 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023.

Footnote F2

The exempt disposition of 8,319 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023.

Footnote F3

On July 19, 2023, the reporting person received a target grant of 57,381 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 16,296 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.